학술논문

Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
Document Type
Article
Source
Quality of Life Research. Jun2013, Vol. 22 Issue 5, p1065-1072. 8p. 5 Charts.
Subject
*CARE of Parkinson's disease patients
*QUALITY of life
*SOCIODEMOGRAPHIC factors
*PERFORMANCE evaluation
*COMPARATIVE studies
*REGRESSION analysis
Language
ISSN
0962-9343
Abstract
Purpose: The EuroQoL (EQ-5D) is ideal to compare quality of life across conditions. However, the Parkinson's Disease Questionnaire (PDQ-39) is often the only quality-of-life instrument used in Parkinson's disease research. We aimed to identify associations between PDQ-39 domains and EQ-5D domains, and compare different methods of developing a function to map the PDQ-39 to EQ-5D scores. Methods: Adults with Parkinson's disease self-completed both instruments. Ordinal regression identified associations between PDQ-39 domain scores and each EQ-5D domain. Modeling ( n = 80) and validation sets ( n = 16) were randomly generated. Overall performance of four methods of mapping the PDQ-39 to EQ-5D scores (using PDQ-39 domains and total score in ordinal and linear regression) was assessed with the validation set, followed by assessing the equivalence of observed and predicted EQ-5D scores on the full dataset controlling for sociodemographic factors. Results: Different sets of PDQ-39 domains were associated with each EQ-5D domain. For example, PDQ-39 'Activities of Daily Living' and 'Social Support' were associated with EQ-5D 'Personal Care,' while PDQ-39 'Emotional Well-being' was associated with EQ-5D 'Anxiety/Depression.' Over one-third (37.5 %) of predictions from ordinal regressions had an error <0.01 % (compared to 6.3 % for linear regressions). The EQ-5D scores predicted with ordinal regression using PDQ-39 domains were similar in distribution and association with sociodemographic factors to the observed EQ-5D scores. Conclusions: Of the four methods tested, using PDQ-39 domains in ordinal regression was superior for mapping EQ-5D scores. The function reported here may prove particularly useful for cost-utility analyses comparing Parkinson's disease with other conditions. [ABSTRACT FROM AUTHOR]